THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

Scientists plan huge painkiller risk study

$100m trial comes in the wake of Vioxx, Bextra withdrawals

By Diedtra Henderson
Globe Staff / December 14, 2005

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

The Cleveland Clinic Foundation said yesterday that it will direct a massive, $100 million clinical trial to assess risks that three popular painkillers may pose to people with heart problems. (Full article: 756 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $9.95 1 month archives pass
  • $24.95 3 months archives pass
  • $74.95 1 year archives pass